METHYLPHENIDATE 20 MG/9 HR PATCH

What it is

METHYLPHENIDATE 20 MG/9 HR PATCH is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methylphenidate, under the trade name “Methylphenidate Transdermal System”.

FDA gives its dosage form as patch and its route as transdermal.

Its labelers, the companies named on the label, are Mylan Pharmaceuticals Inc. and PADAGIS US LLC.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $6.61 for 1 patch (1 × $6.60924 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · NADAC explanation codes

All 4 NDCs

• 00378-8262-16 · not listed as a package in the FDA directory · $6.60924 per EA · eff. 2026-09-23 filed
• 00378-8262-93 · Mylan Pharmaceuticals Inc. · $6.60924 per EA · eff. 2026-09-23 filed
• 00574-2420-01 · not listed as a package in the FDA directory · $6.60924 per EA · eff. 2026-09-23 filed
• 00574-2420-65 · PADAGIS US LLC · $6.60924 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name methylphenidate with METHYLPHENIDATE 20 MG/9 HR PATCH.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $6.60924 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 87 have a higher middle NADAC price and 116 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $9.71 for 1 patch, at an average of $9.71315 per EA in 2024 (2024-01-01 to 2024-12-31) for “Methylphenidate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,098 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 patch? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.